Systems for producing cellular immunotherapeutics and methods of use thereof
US11371008B2 · kind B2 · utility
1Cited by
1References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 3, 2018 |
| Grant date | Jun 28, 2022 |
| Priority date | — |
| Expiry date | Dec 7, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/25
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Devices, systems, and methods can be used for the automated production of dendritic cells (DC) from dendritic cell progenitors, such as monocytes obtained from peripheral blood, and the automated generation of immunotherapeutic products from those dendritic cells, all within a closed system. The invention makes it possible to obtain sufficient quantities of a subject's own DC for use in preparing and characterizing vaccines, for activating and characterizing the activation state of the subject's immune response, and to aid in preventing and/or treating cancer or infectious disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.